Akesiss Pharma Pvt Limited

Akesiss is a rising star in the pharmaceutical industry, launched with the support of a U.S.-based NRI group. With a bold vision and robust domestic reach across India, Akesiss is rapidly expanding across 15 therapeutic segments. Its strategic molecular selections are widely endorsed by the medical fraternity, fueling sustained growth and clinical relevance. Driven by innovation, Akesiss pioneers advanced drug delivery systems, adhering to stringent protocols that maximize efficacy, enhance patient compliance, and minimize side effects, ensuring optimal therapeutic outcomes. Business Divisions: Akesiss operates through seven specialized marketing divisions, each tailored to distinct therapeutic needs. - Zalvo & Zalvo Life: Gynecology, Urology, Pulmonology & General Medicine - Glyvo & Glyvo Life: Endocrinology, Diabetology, Cardiology & General Medicine - Lazo: Orthopedics, Nephrology, General Medicine - CCD: Surgical Specialties - MSD: Multispecialty including Gynecology, General Medicine, Orthopedics Akesiss has secured intellectual property rights for over 80 registered brand names, reinforcing its market presence and product identity. Manufacturing & Export: Megasys Biotek, a subsidiary of Akesiss, is a WHO-GMP certified, state-of-the-art manufacturing facility located in Kerala. Renowned for its consistent quality, diverse product portfolio, and timely delivery, Megasys upholds international standards and has earned accolades from both domestic and global clients. Global Accreditation: Akesiss is ISO 9001:2015 certified by the prestigious Bureau Veritas of France, accredited by UKAS, affirming its commitment to global quality benchmarks. Commitment to Quality: Quality is the cornerstone of Akesiss. All formulations are crafted in advanced, WHO-GMP certified, R&D-driven facilities. By offering international-grade pharmaceuticals at affordable prices, Akesiss ensures wide accessibility and better health outcomes across India and beyond.